Corona Remedies IPO

Corona Remedies IPO: Shares Shine On NSE & BSE With 38% Listing Premium, Signaling Strong Investor Confidence On Dalal Street

Corona Remedies IPO: Shares Shine On NSE & BSE With 38% Listing Premium, Signaling Strong Investor Confidence On Dalal Street

Corona Remedies debuted strongly on Dalal Street, listing at hefty premiums on NSE and BSE after massive IPO demand, signaling…

December 15, 2025

Corona Remedies IPO Opens Strong: High GMP And Long-Term ‘Subscribe’ Rating Boost Investor Interest- Here’s Everything You Need To Know

Corona Remedies IPO opens with strong investor buzz, driven by solid brand strength, high GMP, and long-term growth potential. Though…

December 8, 2025